| Name | tert-butyl 4-(aminomethyl)-4-(4-bromophenyl)piperidine-1-carboxylate |
|---|---|
| Synonyms |
qc-7794
4-aminomethyl-4-(4-bromo-phenyl)-piperidine-1-carboxylic acid tert-butyl ester |
| Molecular Formula | C17H25BrN2O2 |
|---|---|
| Molecular Weight | 369.29700 |
| Exact Mass | 368.11000 |
| PSA | 55.56000 |
| LogP | 4.31470 |
| HS Code | 2933399090 |
|---|
|
~%
849928-29-6 |
| Literature: ASTEX THERAPEUTICS LIMITED; THE INSTITUTE OF CANCER RESEARCH:ROYAL CANCER HOSPITAL; CANCER RESEARCH TECHNOLOGY LIMITED; ASTRAZENECA AB Patent: WO2007/125325 A1, 2007 ; Location in patent: Page/Page column 109-110; 131; 132 ; WO 2007/125325 A1 |
| HS Code | 2933399090 |
|---|---|
| Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |